Magic mushroom therapy targets Cancer-Related anxiety in new trial
NCT ID NCT07072728
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 29 times
Summary
This study tests whether a drug called NPX-5 (psilocybin) combined with talk therapy can reduce severe anxiety in people who have been diagnosed with cancer. About 87 adults aged 18 to 80 will receive one of three doses (25 mg, 10 mg, or 1 mg) during an 8-hour therapy session. The goal is to see if this approach safely eases anxiety and improves quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Empax Centre
RECRUITINGLeederville, Western Australia, 6007, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mind Medicine Australia Clinic
RECRUITINGAbbotsford, Victoria, 3067, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Paratus Clinical Research Melbourne
RECRUITINGNorthcote, Victoria, 3070, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.